← Leaderboards
R. Adams Dudley
University Of California, San Francisco
$6,076,611
Attributed
$7,877,514
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,901,576 · 3
AHRQ$1,975,938 · 2
By mechanism
R01$6,301,555 · 3
T32$1,156,065 · 1
P30$419,894 · 1
Top collaborators
- David H Ingbar2 shared
- Kirsten L Johansen2 shared
- Elaine Ku2 shared
- Chris H Wendt2 shared
- Rui Zhang2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jennifer C. Lai$13,060,291
- Elaine Ku$7,880,686
- Jonathan Paul Singer$10,244,513
- Sheri Ann Lippman$11,125,896
- Meyeon Park$3,628,220
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FutureLifeMedicalModificationHealthcare SystemsCaringMeasurementMortalityCostBilling DataBaseLongevityInstrumentBenefits And RisksEffective InterventionDecision MakingElementsFeedbackCompliance BehaviorCoronary ArteriosclerosisGenerationsAutomobile DrivingDecision AidPatient Education
Grant awards (13)
Racial disparities in access to kidney transplantation$670,663
R01 · FY2025 · DK
Research Education Core$419,894
P30 · FY2025 · HS · contact PI
Racial disparities in access to kidney transplantation$702,928
R01 · FY2024 · DK
Training in Lung Science$324,046
T32 · FY2023 · HL
Training in Lung Science$832,019
T32 · FY2022 · HL
Variation in Provider Breast Cancer Surveillance Strategies Following Initial Treatment: Contribution of Patient and Provider Factors, Association with Outcomes, and Stakeholder Insights$358,427
R01 · FY2019 · HS · contact PI
Variation in Provider Breast Cancer Surveillance Strategies Following Initial Treatment: Contribution of Patient and Provider Factors, Association with Outcomes, and Stakeholder Insights$398,319
R01 · FY2018 · HS · contact PI
Variation in Provider Breast Cancer Surveillance Strategies Following Initial Treatment: Contribution of Patient and Provider Factors, Association with Outcomes, and Stakeholder Insights$399,298
R01 · FY2017 · HS · contact PI
Decisional Quality for Patients with Stable Coronary Artery Disease$803,036
R01 · FY2016 · HL · contact PI
Variation in Provider Breast Cancer Surveillance Strategies Following Initial Treatment: Contribution of Patient and Provider Factors, Association with Outcomes, and Stakeholder Insights$400,000
R01 · FY2016 · HS · contact PI
Decisional Quality for Patients with Stable Coronary Artery Disease$944,830
R01 · FY2015 · HL · contact PI
Decisional Quality for Patients with Stable Coronary Artery Disease$926,251
R01 · FY2014 · HL · contact PI
Decisional Quality for Patients with Stable Coronary Artery Disease$697,803
R01 · FY2013 · HL · contact PI